Close Menu

NEW YORK (GenomeWeb News) – Life Technologies and RainTree Oncology Services today announced a collaborative agreement to bring advances in molecular testing to the broader patient market while developing a streamlined protocol for bringing patients into clinical trials for targeted therapies.

Through the deal, Life Tech intends to participate in developing next-generation sequencing panels for the deep interrogation of tumors. Other assays may also be developed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.